Bicocca Open Archive

Logo unimib boa
OKOLICSANYI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.053
EU - Europa 2.556
AS - Asia 2.536
SA - Sud America 450
AF - Africa 77
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.700
SG - Singapore 907
CN - Cina 631
IT - Italia 556
DE - Germania 390
RU - Federazione Russa 352
BR - Brasile 332
CA - Canada 319
VN - Vietnam 306
SE - Svezia 298
HK - Hong Kong 259
IE - Irlanda 211
UA - Ucraina 175
GB - Regno Unito 165
IN - India 128
FR - Francia 87
DK - Danimarca 68
AT - Austria 67
BD - Bangladesh 54
FI - Finlandia 53
AR - Argentina 43
TR - Turchia 43
IQ - Iraq 31
ES - Italia 28
NL - Olanda 26
MX - Messico 23
ZA - Sudafrica 23
SA - Arabia Saudita 22
BE - Belgio 21
KR - Corea 21
JP - Giappone 19
EC - Ecuador 18
CO - Colombia 16
PK - Pakistan 15
PL - Polonia 15
PH - Filippine 14
VE - Venezuela 12
ID - Indonesia 11
MA - Marocco 11
CL - Cile 9
AE - Emirati Arabi Uniti 8
MY - Malesia 8
DZ - Algeria 7
NP - Nepal 7
TN - Tunisia 7
AU - Australia 6
ET - Etiopia 6
IR - Iran 6
JO - Giordania 6
KE - Kenya 6
PE - Perù 6
PY - Paraguay 6
TW - Taiwan 6
AZ - Azerbaigian 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
EG - Egitto 5
BO - Bolivia 4
JM - Giamaica 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
EU - Europa 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MN - Mongolia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
TH - Thailandia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
GR - Grecia 2
IL - Israele 2
LY - Libia 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
ZM - Zambia 2
A1 - Anonimo 1
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 11.675
Salva come PNG Salva come JPEG
Città #
Ann Arbor 862
Singapore 516
Ashburn 504
Woodbridge 462
Fairfield 339
San Jose 318
Houston 297
Chandler 271
Hong Kong 256
Toronto 236
Wilmington 231
Frankfurt am Main 215
Dublin 203
Dearborn 166
Jacksonville 157
New York 155
Milan 154
Seattle 137
Cambridge 133
Dallas 92
Beijing 91
Los Angeles 85
Santa Clara 84
Princeton 81
Ho Chi Minh City 78
Hanoi 74
The Dalles 67
Vienna 65
Nanjing 64
Chicago 59
Shanghai 53
Rome 51
Altamura 39
Buffalo 39
Lawrence 38
Lauterbourg 34
Moscow 32
Council Bluffs 31
Orem 28
Lachine 26
São Paulo 26
Guangzhou 24
Nanchang 23
Tianjin 23
Boardman 22
Columbus 22
Shenyang 21
Helsinki 20
Washington 19
Dong Ket 18
San Diego 18
Boston 17
Da Nang 16
Fremont 16
Munich 16
Ottawa 16
Brussels 15
Hefei 15
Tokyo 15
Jinan 14
Johannesburg 14
Phoenix 14
Rio de Janeiro 14
Brooklyn 13
Haiphong 13
Manchester 13
Andover 12
Baghdad 12
Kunming 12
Lissone 12
London 12
Warsaw 12
Changsha 11
Edmonton 11
Seoul 11
Dhaka 10
Mountain View 10
Nürnberg 10
Atlanta 9
Brasília 9
Denver 9
Mexico City 9
Montreal 9
New Delhi 9
Salt Lake City 9
Zhengzhou 9
Chennai 8
Falls Church 8
Hangzhou 8
Hebei 8
Hải Dương 8
Jeddah 8
Jiaxing 8
Mumbai 8
Sacramento 8
San Francisco 8
Valencia 8
Amsterdam 7
Buenos Aires 7
Istanbul 7
Totale 7.596
Salva come PNG Salva come JPEG
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 528
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 492
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 458
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 393
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 388
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 364
Health related quality of life in chronic liver diseases 340
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 323
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 323
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 317
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 315
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 304
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 303
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 302
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 300
The impact of liver disease on the health-related quality of life 298
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 291
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 290
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 288
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 288
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 288
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 286
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 283
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 281
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 273
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 272
Health Related Quality of Life in the Major Liver Conditions 270
Difference in health related quality of life of chronic liver diseases and general population 270
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 268
Liver-allocation policies for patients affected by HCC in Europe 266
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 263
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center 255
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 254
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 251
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 245
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 244
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 242
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 235
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 223
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 191
Totale 12.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/2022551 51 59 72 57 16 41 19 41 26 37 38 94
2022/20231.054 106 369 88 90 56 139 21 73 68 3 31 10
2023/2024647 21 27 15 49 58 213 127 24 40 6 5 62
2024/20251.504 86 160 115 47 123 59 99 49 196 260 109 201
2025/20263.868 472 158 303 325 422 187 514 150 315 393 383 246
Totale 12.065